Status:
UNKNOWN
Biological Markers for the Diagnosis of Central Nervous System Infective Diseases
Lead Sponsor:
Xijing Hospital
Conditions:
Infection
Eligibility:
All Genders
13+ years
Brief Summary
Bacterial meningitis is a potentially life-threatening disease that is associated with substantial neurological morbidity and mortality. Accurate diagnosis is essential to improve outcome and prevent ...
Detailed Description
To investigate the diagnosis value of procalcitonin,interleukin-6, agiotensininⅡin the cerebrospinal fluid in the central nervous system infection disease.
Eligibility Criteria
Inclusion
- Aged 13 years or older;
- At least two of the following clinical characteristics:headache, fever, neck stiffness, mental symptoms or consciousness impairment or seizures
- Patients' family signed informed consent.
Exclusion
- Contraindications to lumbar puncture
- Patients with active malignancy
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2017
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02278016
Start Date
August 1 2014
End Date
July 1 2017
Last Update
January 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032